A growing number of patients are losing their kidney allografts due to glomerulonephritis. Although posttransplant IgA nephropathy (IgAN) is regarded as benign, it may lead to late allograft loss in a substantial number of patients. The aim of this study was to evaluate the influence of posttransplant IgAN on long-term transplantation outcomes, risk factors for progression of graft dysfunction, and effectiveness of therapeutic interventions.
Transplantation Institute, Department of Transplant Medicine and Nephrology, Warsaw Medical University, Nowogrodzka 59, 02-006 Warsaw, Poland. jpazik@poczta.fm